Business
Issue of Warrants
Issue of Warrants.
About this update from Coiled Therapeutics Plc
[{"type":"text","content":"\n \n \n 22 June 2022\n \n \n \n \n \n \n \n \n Roquefort Therapeutics plc\n \n \n \n (\"Roquefort Therapeutics\" or the \"Company\")\n \n \n \n \n \n \n \n \n Issue of Warrants\n \n \n \n \n \n \n Roquefort Therapeutics (LSE:ROQ), the Main Market listed biotech company focused on early-stage opportunities in the biotechnology sector, announces the following issue of warrants to recently appointed Non-Executive Directors and an advisor to the Board:\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Name\n \n \n \n \n \n \n Position\n \n \n \n \n \n \n Number of Warrants Issued\n \n \n \n \n \n \n Total Number of Warrants Held After Issue\n \n \n \n \n \n \n \n Ms Jean Duvall\n \n \n \n \n Non-Executive Director\n \n \n \n \n 300,000\n \n \n \n \n 300,000\n \n \n \n \n \n \n Dr Simon Sinclair1\n \n \n \n \n Non-Executive Director\n \n \n \n \n 300,000\n \n \n \n \n 300,000\n \n \n \n \n \n \n Prof. Trevor Jones\n \n \n \n \n Board Advisor\n \n \n \n \n 300,000\n \n \n \n \n 300,000\n \n \n \n \n \n \n \n 1\n \n Warrants held in the name of Livingstone Investment Holdings Ltd, a company in which Dr Sinclair has a beneficial interest\n \n \n \n \n \n The warrants have been issued in relation to the appointment of the abovenamed earlier this year and form part of their annual remuneration package.\n \n \n \n \n \n The warrants have a term of 5 years and are exercisable at a price of 15 pence, with 50% exercisable after 12 months and the balance exercise after 24 months.\n \n \n \n \n \n Enquiries:\n \n \n \n \n \n \n \n Roquefort Therapeutics plc\n \n \n \n \n \n \n \n Stephen West (Chairman)\n \n \n \n \n +44 (0)20 3290 9339\n \n \n \n \n \n \n \n \n \n \n Buchanan (Public Relations)\n \n \n \n Ben Romney / Jamie Hooper / George Beale\n \n \n \n \n \n \n \n \n Optiva Securities Limited (Broker)\n \n \n \n \n \n \n \n \n +44 (0)20 7466 5000\n \n \n \n \n \n \n Christian Dennis\n \n \n \n \n +44 (0)20 3411 1881\n \n \n \n \n \n \n \n \n \n \n \n For further information on Roquefort Therapeutics, please\n visit\n \n www.roquefortplc.com\n \n and\n @RoquefortTherap\n on Twitter.\n \n \n \n \n \n LEI: 254900P4SISIWOR9RH34\n \n \n \n \n About Roquefort Therapeutics\n \n \n \n Roquefort Therapeutics (LSE:ROQ) is a Main Market listed biotech company developin...